Does NATALIZUMAB Cause Multiple sclerosis relapse? 6,478 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6,478 reports of Multiple sclerosis relapse have been filed in association with NATALIZUMAB (TYRUKO). This represents 10.1% of all adverse event reports for NATALIZUMAB.
6,478
Reports of Multiple sclerosis relapse with NATALIZUMAB
10.1%
of all NATALIZUMAB reports
96
Deaths
3,253
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From NATALIZUMAB?
Of the 6,478 reports, 96 (1.5%) resulted in death, 3,253 (50.2%) required hospitalization, and 55 (0.8%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 6,478 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
Asthenia (1,945)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
PEGINTERFERON BETA-1A (945)
Which NATALIZUMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK